Angiotensin, transforming growth factor β and aortic dilatation in Marfan syndrome: Of mice and humans
Marfan syndrome is consequent upon mutations in FBN1, which encodes the extracellular matrix microfibrillar protein fibrillin-1. The phenotype is characterised by development of thoracic aortic aneurysm. Current understanding of the pathogenesis of aneurysms in Marfan syndrome focuses upon abnormal...
Main Authors: | Christopher Yu, Richmond W. Jeremy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | International Journal of Cardiology: Heart & Vasculature |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906717300714 |
Similar Items
-
17 β-Estradiol Impedes Aortic Root Dilation and Rupture in Male Marfan Mice
by: Louis Saddic, et al.
Published: (2023-09-01) -
Aortic Root Dilatation and Marfan’s Syndrome: An Alternative Diagosis
by: Sheraz Younas, et al.
Published: (2020-12-01) -
Vitamin B Mitigates Thoracic Aortic Dilation in Marfan Syndrome Mice by Restoring the Canonical TGF-β Pathway
by: Tzu-Heng Huang, et al.
Published: (2021-10-01) -
The prevalence of obstructive sleep apnoea and its association with aortic dilatation in Marfan's syndrome.
by: Kohler, M, et al.
Published: (2009) -
Losartan in combination with propranolol slows the aortic root dilatation in neonatal Marfan syndrome
by: Lu-Hang Liu, et al.
Published: (2018-04-01)